Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Apr 13, 2021 3:05pm
181 Views
Post# 32986607

RE:RE:RE:NYTimes:Hungry for Investors, Some Companies Woo the Little

RE:RE:RE:NYTimes:Hungry for Investors, Some Companies Woo the Little Four of board members are retirees including the chairwoman although I don't believe that automatically disqualifies them as active, versatile, innovative professionals but I think as one get older usually not always it gets harder to adapt.
Also it gets harder to stay motivated the longer you have been in the same position.
The two new comers so far only have been contributed to the expenses. Paul joined the company in right time with fresh ideas, loads of motivation as this is his first position as a CEO.
He is young but also experienced. This is what we need new leaders with desire to make an impact at the same time mentally young enough to be open to new ideas this is in my opinion is what this company needs.
<< Previous
Bullboard Posts
Next >>